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Abstract
Background: Ureteral strictures are a recurrent chronic condition that leads to severe side effects and poor
quality of life. Management of ureteral stricture is a great challenge for urologists and no specific guidelines
exist. Retrograde Allium ureteral stent (AUS) is a newly developed ureteral stent to treat either bulbar
urethral or ureteral stenosis.
Case Presentation: We describe a case of a 74-year-old Caucasian adult male presenting with a severe ureteral
stricture secondary to an ureteroscopy for stone disease. Treatment with retrograde AUS placement produced a
complete loss of renal function after 36 months, probably because of the development of a long achalasic stretch
of the ureter.
Conclusions: AUS is a new and promising device for the treatment of ureteral stenosis. However, a lack of
standardization of the technique recommends a close instrumental follow-up after the procedure to decide the
optimal time for stent removal.
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Introduction and Background
Ureteral stricture is a well-known complication af-ter endoscopic procedures in the upper urinary tract.1
However, the exact mechanism for which stenosis develops
is not well known. Some studies have revealed that in case of
impacted calculi, ureteral perforation during the procedure is
related to a high rate of stricture development (90% to 95%).2
Damage to the ureteral mucosa can also trigger stricture
formation. Fibrinous exudates produced by the mucosa pre-
cipitate into the injured area, stimulating adherence and, fi-
nally, stricture formation.3 Management of ureteral strictures
is a great challenge for urologists.
To date, we have no specific recommendations on how to
treat ureteral stenosis. Traditionally, the open surgical treatment
of ureteral strictures included ureteroureteral anastomosis,
ileal substitution, autotransplant, or nephrectomy. With the
technological evolution, endoscopic treatments such as balloon
dilatation, cold knife incision, and laser endoureterotomy are
more commonly used, including the insertion of new types of
ureteral stent.4 The Allium ureteral stent (AUS) is a newly
developed ureteral stent, which can be inserted in structures of
small diameter and spontaneously expands and preserves a
large caliber. The stent is coated with a biochemical copolymer
that prevents tissue ingrowth and incrustation.5 The stent can be
inserted endoscopically with an intraoperative X-ray guidance
after dilatation of the stricture and then it can be removed in a
time range from 6 to 12 months. We present the case of a man
with a complete loss of left kidney function after positioning of
the AUS for an indwelling time of 36 months.
Case Presentation
On March 2013, a 74-year-old Caucasian man with
a history of stone disease was evaluated in our urologic
department for left side pain. Medical history included
only hypertension under control with beta-blockers. Ultra-
sonography (US) showed a severe left hydroureteronephrosis
and an X-ray revealed an impacted stone of about 13mm
diameter at the level of the iliac tract of the ureter. Laboratory
tests were unremarkable except for increased creatinine up to
1.5mg/dL. There was no leukocytosis. Ureteroscopy (URS)
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with holmium laser fragmentation was performed and a
Double-J stent was inserted for edema and inflammation of
the ureteral walls in the side of the stone. Double-J stent was
removed after 15 days. After 30 days from stent removal, the
patient referred a mild left flank pain and US showed a
moderate hydroureteronephrosis. An X-Urography showed a
4 cm stenosis of the iliac tract of the left ureter. A kidney
scintigraphy showed a normal renal function. In accordance
with the patient, it was decided to proceed endoscopically to a
balloon dilatation of the stenosis followed by the positioning
of an AUS (Fig. 1). At 1-month follow-up, US showed a slight
dilation of left renal pelvis (Grade-I) and the same situation
was maintained at 3- and 6-month follow-ups. Subsequently
the patient was lost in the follow-up for severe cardiovascular
problems. He came back again to our department after 2 years
from the last control, without any sign or symptom. An US
showed a severe left hydroureteronephrosis with a marked
thinning of the renal parenchyma and a secondary stone of
about 15mm. An abdomen X-ray showed the AUS in the
original position. A kidney scintigraphy was planned and it
showed the complete loss of left kidney function. Considering
the general conditions of the patient (ASA score IV) and the
lack of symptoms, we decided to follow the patient at regular
intervals and to be operated only in case of complications.
Discussion
Ureteral strictures are a recurrent chronic condition that
leads to severe side effects and poor quality of life. Man-
agement of ureteral strictures is a great challenge for urolo-
gists and no specific guidelines exist.
There are several options, including repeated dilatations,
stents, minimally invasive reconstructive surgery, and uri-
nary diversion or nephrectomy. AUS is a new device recently
introduced to treat ureteral and urethral stenosis. Considering
the recent introduction into the clinical practice, we have
only few studies on AUS for ureteral strictures and mainly
we do not have specific indications on when to remove the
AUS. Moreover, another open question is whether the AUS
can be considered a permanent device, for example, in the
management of ab-estrinseco compression of the ureter from
oncologic diseases. Since 2014, we have treated >50 cases
of urethral stenosis with AUS, obtaining good functional
results. We believe that the optimal time to remove the stent
should be between 6 and 12 months. We reported a case in
whom after 36 months of Allium positioning, it developed a
severe hydronephrosis with a complete loss of left kidney
function probably because of the formation of a long acalasic
stretch of the ureter in the side of the AUS. We can hypoth-
esize that the presence of the stent in the wall of the ureter for
a long period of time can trigger inflammation and a subse-
quent fibrosis with loss of normal ureteral peristalsis. Another
hypothesis is that in our case, the stenosis was very severe and
the marked dilation produced a stripping and tearing of the
fibromuscular component of the ureter, resulting in fibrosis
and loss of physiologic peristaltic function. Unfortunately,
we did not have the possibility to perform an URS at a shorter
follow-up from the procedure to confirm this second hy-
pothesis. Some studies5–7 have reported stent migration or
infection as complications of AUS. We believe that the de-
velopment of ureteral achalasia should also be considered as
a possible complication of AUS.
Conclusions
AUS is a new and promising device for the treatment of
ureteral stenosis. Some studies have reported promising re-
sults for the treatment of ureteral stenosis. However, there is a
lack of standardization of the technique and predictive factors
of success or complications have not been determined. For
these reasons, we recommend a close instrumental follow-up
in the early months after the procedure so to decide the op-
timal removal time of the stent or to identify a progressive
hydronephrosis as a marker of possible failure.
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FIG. 1. Abdomen X-ray showing Allium ureteral stent
positioning in the iliac tract of the left ureter.
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